Answers are grounded in this paper and cite their sources.
Determines optimal cutoffs for HOMA-IR and HOMA-B in renal transplant recipients, suggesting potential early risk assessment tools for PTDM.
Background: Diabetes mellitus occurs in a substantial number of patients following renal transplantation. The presence of Insulin resistance in diabetics can be assessed by the Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) and the Homeostasis Model Assessment Beta cell dysfunction (HOMA-B). The optimal cutoffs for HOMA-IR and HOMA-B and the diagnostic performance of predictors for Posttransplant Diabetes Mellitus (PTDM) in the Indian population are not precisely known. Objectives: Our study was aimed at determining the optimal cutoffs for HOMA-IR and HOMA-B in renal transplant recipients who developed PTDM, as well as to determine the diagnostic performance of the parameters for prediction in kidney transplant recipients who develop PTDM. Materials and Methods: The HOMA 2 calculator was used to determine HOMA-IR and HOMA-B in 58 living related donor renal transplant recipients who underwent transplantation in our center and followed up for a mean period of 12 months (range: 6–24 months) after transplantation. Results: For HOMA-IR, a cut-off value of 1.76 and for HOMA-B, 73.5% were obtained, indicating that values above this level significantly increase the risk of PTDM. Cumulative Prednisolone dose at 3 months after transplant, HOMA-B posttransplant, total calorie intake posttransplant, HOMA-IR posttransplant, body mass index posttransplant, and serum fasting Insulin levels were identified as significant predictors of PTDM. Conclusion: The identified cutoffs and diagnostic parameters can be used as early risk assessment tools for the development of PTDM in renal transplant recipients.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: